Fundamental study about the cancer-of-the-mouth stem cell andmolecular target drug under low oxygen environment

根据迄今为止获得的结果，mTOR抑制药物对口腔鳞状细胞癌的增殖效力控制，以及对不仅参与破坏癌干细胞功能的维持而且参与淋巴结转移的基因的控制是有效的，并且提出了将mTOR抑制药物应用于口腔癌作为未来新的分子靶向医学治疗的可能性。

By the result obtained until now, a mTOR inhibitory drug Proliferation potency control of oral squamous cell carcinoma, Also to the control of a gene which participates not only in ruining maintenance of a cancer stem cell function but in lymph node metastasis, it is effective and the possibility that the application to the cancer of the mouth of a mTOR inhibitory drug was useful as future new molecular target medical treatment was suggested.